Leucadia Pharmaceuticals is offering acetaminophen injection, in a dosage strength of 1000 mg/100 ml (10 mg/ml).
The product is the generic of Mallinckrodt’s Ofirmev.
It is indicated for the management of mild to moderate pain, management of moderate to severe pain with adjunctive opioid analgesics and reduction of fever.
“The release of this latest generic injectable once again demonstrates Leucadia’s strategic focus on expanding access to safe, effective pharmaceuticals at substantially lower costs,” said William Larkins, Leucadia CEO. “Acetaminophen Injection is a widely proven therapy for the reduction of pain and fever and demand for expanded options in this market is extremely robust.”